GSK vs SNY
GSK plc and Sanofi, both Healthcare
GSK plc is the larger company at $104B against $100B. Over the past year GSK returned +17% against -11% for SNY. The RyuScore puts GSK ahead, 67 against 55 out of 100.
| Figure | GSK | SNY |
|---|---|---|
| Last close | $46.51 | $40.07 |
| Market cap | $104B | $100B |
| 1-year return | +17% | -11% |
| 5-year return | +43% | +2.8% |
| RyuScoresector-relative, 1–10 | 67/100 | 55/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
GSK plc
Sanofi
Revenue of $24B in H2 2025, net income $2.0B.
Open these two in the interactive comparison to add more names, change the period or see the correlation.